Giollo, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 3.039
EU - Europa 2.979
AS - Asia 2.116
SA - Sud America 293
AF - Africa 60
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.508
Nazione #
US - Stati Uniti d'America 2.958
RU - Federazione Russa 1.340
CN - Cina 772
SG - Singapore 761
GB - Regno Unito 396
IT - Italia 250
BR - Brasile 237
DE - Germania 224
IE - Irlanda 193
HK - Hong Kong 191
SE - Svezia 186
FR - Francia 170
VN - Vietnam 116
FI - Finlandia 73
IN - India 59
KR - Corea 53
JP - Giappone 46
CA - Canada 39
MX - Messico 33
UA - Ucraina 28
AR - Argentina 24
TR - Turchia 23
PL - Polonia 20
EG - Egitto 19
NL - Olanda 18
BE - Belgio 17
AU - Australia 13
ES - Italia 13
ZA - Sudafrica 13
IR - Iran 11
ID - Indonesia 10
PK - Pakistan 9
BD - Bangladesh 8
IQ - Iraq 8
CL - Cile 7
CO - Colombia 7
PT - Portogallo 7
RO - Romania 7
VE - Venezuela 7
UZ - Uzbekistan 6
GR - Grecia 5
MA - Marocco 5
PS - Palestinian Territory 5
TW - Taiwan 5
AT - Austria 4
IL - Israele 4
KE - Kenya 4
PE - Perù 4
TD - Ciad 4
TG - Togo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
BJ - Benin 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
LV - Lettonia 3
MY - Malesia 3
PH - Filippine 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
BG - Bulgaria 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
KW - Kuwait 2
LT - Lituania 2
MK - Macedonia 2
MN - Mongolia 2
PY - Paraguay 2
SN - Senegal 2
UY - Uruguay 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CD - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EU - Europa 1
GF - Guiana Francese 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
PA - Panama 1
PF - Polinesia Francese 1
Totale 8.501
Città #
Dallas 553
Moscow 509
Chandler 437
Southend 350
Singapore 308
Ashburn 252
Hong Kong 189
Dublin 186
Redmond 148
Beijing 126
Jacksonville 108
New York 82
Lawrence 66
Princeton 66
Wilmington 64
Jinan 60
Los Angeles 59
Houston 57
Ann Arbor 53
Shenyang 47
Helsinki 43
Munich 43
Tokyo 42
Nanjing 41
Bologna 40
Woodbridge 38
Buffalo 37
Sindelfingen 37
Ho Chi Minh City 33
Verona 33
Hebei 32
Redondo Beach 30
Hanoi 27
Tianjin 26
Guangzhou 23
Haikou 23
The Dalles 22
São Paulo 21
Changsha 20
Hangzhou 20
Ningbo 20
San Francisco 20
Redwood City 19
Seattle 19
Zhengzhou 19
Columbus 17
Santa Clara 17
Washington 17
Warsaw 16
Denver 15
Taiyuan 15
Taizhou 15
Turku 15
Brussels 14
Rome 14
Boston 13
Hyderabad 13
London 13
Fairfield 12
Montreal 12
Nanchang 12
Orem 12
Toronto 12
Jiaxing 11
Norwalk 11
Chicago 10
Falkenstein 10
Falls Church 10
Poplar 10
Atlanta 9
Detroit 9
Frankfurt am Main 9
Johannesburg 9
Milan 9
Phoenix 9
Stockholm 9
Brooklyn 8
Cairo 8
Jakarta 8
Lanzhou 8
Monterrey 8
Amsterdam 7
Ankara 7
Brescia 7
Dong Ket 7
Fuzhou 7
Mexico City 7
Belo Horizonte 6
Campinas 6
Da Nang 6
Esslingen am Neckar 6
Karachi 6
Manchester 6
Rio de Janeiro 6
Seoul 6
Shanghai 6
Tashkent 6
Biên Hòa 5
Council Bluffs 5
Düsseldorf 5
Totale 4.984
Nome #
A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis 290
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 221
Investigational echocardiography for the detection of heart involvement in rheumatic musculoskeletal diseases 211
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 188
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 185
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 176
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 169
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 168
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 160
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 149
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 140
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 137
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 136
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 135
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 133
Biologics for Eosinophilic Granulomatosis with Polyangiitis: one size does not fit all 133
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 132
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study 131
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 131
Association between environmental air pollution and rheumatoid arthritis flares 130
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 129
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 128
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 128
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study 127
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis 120
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 120
Rheumatoid arthritis, γδ T cells and bisphosphonates 119
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 118
The obesity paradox and osteoporosis 117
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 117
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 117
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 116
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 115
Effects of secukinumab on serum adipocytokines: preliminary data 114
Osteoporosis in Rheumatic Diseases 114
Strong relationship between vitamin D status and bone mineral density in anorexia nervosa 114
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 113
High prevalence of occult heart disease in normotensive patients with rheumatoid arthritis 110
Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica is Uncommon but May Be Enhanced by Amino Bisphosphonates 110
Correction to: The obesity paradox and osteoporosis 108
Efficacy of interleukin-1 blockade in Schnitzler's syndrome without detectable monoclonal gammopathy: a case-based review 108
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 107
Prevalence and factors related to inappropriately high left ventricular mass in patients with rheumatoid arthritis without overt cardiac disease 106
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 106
Traditional cardiovascular risk factors or inflammation: Which factors accelerate atherosclerosis in arthritis patients? 104
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 104
Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system - An overlooked association? 103
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 102
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 102
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 102
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 101
Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease 101
Disease activity and left ventricular systolic function in rheumatoid arthritis 100
Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients 100
Tuberculosis Infection Despite Isoniazid Prophylaxis in a Patient With Psoriatic Arthritis Treated With Etanercept 96
Incidence and predictors of adverse clinical events in patients with rheumatoid arthritis and asymptomatic left ventricular systolic dysfunction 96
Prognostic Role of Subclinical Left Ventricular Systolic Dysfunction Evaluated by Speckle-Tracking Echocardiography in Rheumatoid Arthritis 95
Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review 95
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 93
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 92
Ultrasonography of the nail unit reveals quantitative and qualitative alterations in patients with psoriasis and psoriatic arthritis 91
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 91
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 91
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 88
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 86
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 85
Incidence and predictors of new onset left ventricular diastolic dysfunction in asymptomatic patients with rheumatoid arthritis without overt cardiac disease 82
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 79
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 74
The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohort 70
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 67
Subclinical Myocardial Fibrosis in Systemic Lupus Erythematosus as Assessed by Pulse-Cancellation Echocardiography: A Pilot Study 52
Early characterization of difficult-to-treat rheumatoid arthritis by suboptimal initial management: a multicentre cohort study 44
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 32
Intensive therapeutic plasma exchange in life-threatening ANCA-associated vasculitis 23
Sequential Treatment of Osteoporosis 8
Totale 8.685
Categoria #
all - tutte 32.745
article - articoli 32.214
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 501
patent - brevetti 0
selected - selezionate 0
volume - volumi 30
Totale 65.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021354 0 0 0 0 101 52 26 5 74 6 54 36
2021/2022640 69 175 4 40 29 18 14 29 55 17 33 157
2022/20231.255 80 133 105 220 118 281 30 61 154 15 44 14
2023/2024695 33 45 74 83 77 132 34 38 10 28 106 35
2024/20251.548 65 89 58 270 121 40 92 63 216 121 122 291
2025/20263.048 306 235 564 801 1.142 0 0 0 0 0 0 0
Totale 8.685